GSK3β binding of GSKIP affects neurite outgrowth, but the physiological significance of PKA binding to GSKIP remains to be determined. We hypothesized that GSKIP and GSK3β mediate cAMP/PKA/Drp1 axis signaling and modulate mitochondrial morphology by forming a working complex comprising PKA/GSKIP/GSK3β/Drp1. We demonstrated that GSKIP wild-type overexpression increased phosphorylation of Drp1 S637 by 7-8-fold compared to PKA kinase-inactive mutants (V41/L45) and a GSK3β binding-defective mutant (L130) under H 2 O 2 and forskolin challenge in HEK293 cells, indicating that not only V41/L45, but also L130 may be involved in Drp1-associated protection of GSKIP. Interestingly, silencing either GSKIP or GSK3β but not GSK3α resulted in a dramatic decrease in Drp1 S637 phosphorylation, revealing that both GSKIP and GSK3β are required in this novel PKA/GSKIP/GSK3β/Drp1 complex. Moreover, overexpressed kinase-dead GSK3β-K85R, which retains the capacity to bind GSKIP, but not K85M which shows total loss of GSKIP-binding, has a higher Drp1 S637 phosphorylation similar to the GSKIP wt overexpression group, indicating that GSK3β recruits Drp1 by anchoring rather than in a kinase role. With further overexpression of either V41/L45P or the L130P GSKIP mutant, the elongated mitochondrial phenotype was lost; however, ectopically expressed Drp1 S637D, a phosphomimetic mutant, but not S637A, a non-phosphorylated mutant, restored the elongated mitochondrial morphology, indicating that Drp1 is a downstream effector of direct PKA signaling and possibly has an indirect GSKIP function involved in the cAMP/PKA/Drp1 signaling axis. Collectively, our data revealed that both GSKIP and GSK3β function as anchoring proteins in the cAMP/PKA/Drp1 signaling axis modulating Drp1 phosphorylation.
Introduction
Glycogen synthase kinase 3 (GSK3), a serine/threonine kinase, participates in several signaling pathways, including the protein kinase A (PKA), protein kinase B (PKB), protein kinase C (PKC), and Wingless (Wnt) pathways. This protein plays a multifaceted physiological role in the regulation of cell fate, signal transduction, protein synthesis, glycogen metabolism, mitosis, and apoptosis [1, 2] . Two structural homologues, GSK3α and GSK3β, have been described in mammals. Differences in the developmental expression profile of GSK3α and GSK3β imply that the regulation and functions of these 2 proteins are not always identical [3] . GSK3β plays an important role in neuron development by regulating the specification of axons and dendrites [4, 5] . Our previous work also showed that GSK3β activity is negatively regulated Biochimica et Biophysica Acta 1853 (2015 [1796] [1797] [1798] [1799] [1800] [1801] [1802] [1803] [1804] [1805] [1806] [1807] by GSKIP. Overexpression of GSKIP prohibits retinoic acid (RA)-induced neurite outgrowth in SH-SY5Y, a neuron-like cell line. While GSKIP increases β-catenin nuclear translocation and enhances cyclin D1 expression, it down-regulates N-cadherin expression to promote cell cycle progression in SH-SY5Y cells [6] .
Our previous work demonstrated that GSK3β also binds to Drp1 and is involved in regulating mitochondrial morphology [7] . Drp1 is one of the dynamin-related proteins, a large protein with an amino-terminal GTPase domain, middle domain, insert B, and GTPase effector domain (GED) [8] . Drp1 participates in cellular events that affect the shape, size, distribution, remodeling, and maintenance of mitochondria in mammalian cells [9] . Phosphorylation is an important regulator of Drp 1 activity. Interestingly, phosphorylation of Drp 1 at multiple serine residues has opposing functional and morphological effects [7, [10] [11] [12] [13] [14] [15] [16] [17] [18] . Drp1 S637 was first identified as a phosphorylation site for PKA and as a dephosphorylation site for calcineurin [12] [13] [14] . Phosphorylation at Drp1 S637 leads to an elongated mitochondrial morphology. Previous studies have indicated that phosphorylation at Drp1 S637 has beneficial effects in starvation conditions, where mitochondrial are observed to be elongated [19, 20] and unite to survive [21] by protecting mitochondria from autophagosomal degradation, permitting mitochondria to maximize energy production and supplying autophagosomal membranes [22] . In addition, GSK3β-mediated phosphorylation of Drp1 S693 is important in controlling mitochondrial morphology under oxidative stress [7] . However, the physiological role of such phosphorylation events remains unclear.
GSKIP is a small AKAP that complexes with PKA and GSK3β and is known to act synergistically with cAMP/PKA signaling to inhibit GSK3β activity [23] . GSKIP also interacts directly with GSK3β, negatively regulating GSK3β signaling [24] . According to our previous findings, GSK3β binding of GSKIP is involved in the control of neurite outgrowth [6] . However, the cellular consequences of PKA binding to GSKIP remain to be determined.
In this study, we tested: 1) Whether GSKIP and GSK3β mediate cAMP/PKA/Drp1 axis signaling and contribute to morphological modulation of mitochondria by forming a working complex comprising PKA, GSKIP, GSK3β, and Drp1; 2) Whether and how PKA regulates Drp1 phosphorylation via the PKA/GSKIP/GSK3β/Drp1 signaling axis while inhibiting GSK3β activity; and 3) Whether GSK3β recruits Drp1 by anchoring or by a kinase role. We concluded that both GSKIP and GSK3β function as anchoring proteins involved in cAMP/PKA/Drp1 axis signaling, modulating Drp1 phosphorylation at Ser637 rather than Ser693. This is the first report of the anchoring role of GSK3β in the PKA/ GSKIP/GSK3β/Drp1 signaling axis, potentially offering new insights into the multifaceted role of GSK3β.
Methods

Cell culture, differentiation and treatment
Human neuroblastoma SH-SY5Y, HeLa, and HEK293 cell lines (American Type Culture Collection, Manassas, VA, USA) were used for these experiments. SH-SY5Y cells were cultured in DMEM/F12, and HeLa and HEK293 cells were cultured in DMEM (GIBCO BRL Life Technologies, Invitrogen Corporation, CA, USA). All media were supplemented with 10% FBS, penicillin (100 U/mL), and streptomycin (100 μg/mL). All cells were incubated at 37°C with humidification and 5% CO 2 . Cells were cultured in 100-mm diameter dishes and fed once every three days until they reached 70% confluence. To induce neuronal differentiation, SH-SY5Y cells were seeded at 1 × 10 6 
Cloning and DNA sequencing
To construct GFP-tagged wt and mutant GSKIP, DNA fragments encoding GSKIP were amplified by PCR using Taq polymerase (TaKaRa/ Clontech, Madison, WI, USA). The PCR fragments were then inserted into the BamHI and XhoI sites of the pEGFP (Clontech) vector. Sitedirected mutagenesis was used to create the GSKIP L130P (Leucine 130 to Proline) and V41/L45P (Valine 41 and Leucine 45 to Proline) mutants using a Quickchange Lightning kit (GE Healthcare, Sunnyvale, CA, USA) according to the manufacturer's protocol. The nucleotide sequencing reaction was performed with a BigDye Terminator v3.1 Cycling Sequencing kit (Applied Biosystems, Waltham, MA, USA) and the extended products were resolved on an ABI PRISM 3730 Genetic Analyzer (Applied Biosystems, Forster City, CA, USA).
Transfection and RNA interference
For transient transfections, SH-SY5Y, HeLa, and HEK293 cells were seeded onto glass coverslips at a density of 1 × 10 5 cells per 12-well plate. pEGFP, pEGFP-GSKIP, pEGFP-GSKIP (L130P), pEGFP-GSKIP (V41/ L45P), pEGFP-Drp1 (S637D), or pEGFP-Drp1 (S637A) plasmid DNA (1 μg) was transfected into the cells using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. After 24 h transfection, the SH-SY5Y cells were driven to differentiate by adding 10 μM of RA and incubating for five days. For Western blots and immunofluorescence, SH-SY5Y, HeLa, and HEK293 cells were transfected with DNA (1 μg) and Lipofectamine 2000 (3 μL).
After 24 h transfection, the cells were cultured in fresh medium and further assayed. Three different siRNA and scrambled siRNA duplexes were used for RNA interference assays: GSKIP (c14orf129), GSK3α, and GSK3β. For the siRNA-mediated knockdown of GSKIP expression, approximately 1 × 10 5 or 1 × 10 6 cells were plated onto 12-well plates or 100 mm dishes and left to grow overnight. The following day, cells were transfected with the siRNA duplex (final concentration, 50 nM) using Lipofectamine 2000.
Quantitative PCR
cDNA was synthesized from total RNA for each of the studied groups using an ImpronII reverse transcriptase kit (Promega, Madison, WI, USA). All primer pairs with respect to GSKIP, LC3B and GAPDH were designed using a web-based program provided by GeneScript.com. All were assessed and demonstrated: 1) high amplification efficiency (N 96%) across a wide range of cDNA dilutions; 2) specific, single products in dissociation curve analysis; and 3) melting temperatures similar to those predicted by oligonucleotide software. Quantitative PCR was performed using Power SYBR Green dye and the ABI Step One Plus Real Time PCR System (Applied Biosystems, Foster City, CA, USA). The difference between the cycle thresholds (dCT) for target gene (GSKIP and LC3B) mRNA expression was calculated by subtracting the geometric mean of the cycle threshold for the reference gene (GAPDH) from the cycle threshold of GSKIP mRNA. Because this dCT represents the log 2 -transformed expression ratio of the target transcript to the geometric mean of the reference gene, the relative expression level of target gene mRNA was determined as 2-dCT. The relative target gene expression between groups was shown as fold-increases with standard deviations.
Immunofluorescence and microscopy
For immunofluorescent labeling, cell cultures were rinsed several times with PBS, fixed in 4% paraformaldehyde for 5 min, and permeabilized with 0.5% Triton X-100 in PBS for 5 min. Fixed cells were rinsed in PBS, and nonspecific binding was blocked with 5% normal goat serum/1% bovine serum albumin in PBS (pH 7.4) for at least 30 min at 37°C. All subsequent antibody incubations were carried out in the same blocking solution. After a brief wash, the cells were incubated for 45 min at 37°C with the primary antibody anti-NF-200 (monoclonal; 1:500 dilution; Sigma, St. Louis, MO, USA) or anti-GFP (polyclonal; 1:100 dilution; Santa Cruz Biotechnology, Santa Cruz, CA, USA). After extensive washes with PBS, the cultures were incubated with the appropriate secondary antibody conjugated to either Alexa 488 or Alexa 568 (1:500 dilution; Molecular Probes, Eugene, OR, USA) for 45 min at 37°C. Finally, the cells were incubated for 5 min with 4′-6-diamidino-2-phenylindole (DAPI; 1 mg/mL; Hoffman-La Roche, Basel, Switzerland) prior to mounting (Molecular Probes, Eugene, OR, USA). Confocal images were obtained using an Olympus IX71 microscope (using an NA 1.3, 100× Plan objective) at 0.2 mm z-steps, controlled by FLUOVIEW software (Universal Imaging, Bedford Hills, NY, USA). All images were imported into Adobe Photoshop CS5.1 for contrast manipulation (Mitotracker and DAPI).
Western blotting and caspase activity measurement
Cell lysates were prepared using RIPA buffer, and lysate protein concentrations were determined using the Bio-Rad Protein Assay system (BioRad, Hercules, CA, USA). Nuclear extracts were prepared using the Nuclear/Cytosol Fractionation kit (Biovision Research, Milpitas, CA, USA) according to the manufacturer's instructions. Proteins were separated by 12% SDS-PAGE and transferred onto PVDF membranes. The membrane was then incubated with primary antibodies: anti-GSK-3 (recognizing both GSK-3α and GSK-3β; Santa Cruz Biotechnologies), anti-GSK3β (BD Biosciences, Franklin Lakes, NJ, USA), anti-phospho (S9)-GSK3β (Cell Signaling Technology, Danvers, MA, USA), antiphospho (S637)-Drp1, anti-phospho-PKA substrates, anti-LC3B, antiAtg5, anti-PARP (cleavage form), anti-caspase-9/-3 (Cell Signaling Technology, Danvers, MA, USA), anti-p62 (AbCam, Cambridge, England), anti-GFP, anti-β-catenin, anti-β-actin (Santa Cruz Biotechnology, Santa Cruz, CA, USA), and anti-Drp1 (BD Biosciences, San Jose, CA, USA). The secondary antibodies used were goat anti-mouse or anti-rabbit IgG conjugated to HRP (Zymed/Invitrogen, Carlsbad, CA, USA). ECL reagents (GE Healthcare, Little Chalfont, UK) were used to detect chemiluminescent signaling. Apoptosis was measured using a luminogenic caspaseGlo 3/7 reagent according to the manufacturer's instructions (Promega, Madison, WI, USA).
Immunoprecipitation
HEK293 cells (1 × 10 6 ) were transfected with pEGFP-GSKIP wildtype, pEGFP-GSKIP L130P, or pEGFP-GSKIP V41/L45P DNA for 24 h. The cells were harvested and washed with phosphate-buffered saline. The lysates were prepared by the addition of immunoprecipitation assay buffer (1 mL; 50 mM Tris-HCl, pH 7.8, 150 mM NaCl, 5 mM EDTA, 0.5% Triton X-100, 0.5% Nonidet P-40, 0.1% deoxycholate, and 10 mg/mL each of leupeptin, aprotinin, and 4-[2-aminoethyl] benzene sulfonyl fluoride) to the cells. Lysates were then microcentrifuged at 10,000 × g for 20 min and the supernatants treated with anti-GSK3β antibody (BD Biosciences, Franklin Lakes, NJ, USA) at 48°C for 1 h. Protein-A/G Agarose beads (30 mL) (Calbiochem, Davis, CA, USA) were added to the lysates, and the mixtures were incubated with shaking for 1 h at 48°C. The beads were finally collected by centrifugation and washed three times with immunoprecipitation assay buffer. Proteins bound to the beads were eluted with electrophoresis sample buffer (20 mL) and separated by SDS-PAGE. Immunoblots were visualized using anti-GFP antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-Drp1 antibody (BD Biosciences, San Jose, CA, USA), or anti-PKA RII antibody (Merck Millipore, Darmstadt, Germany).
In vitro kinase assay
The kinase reaction was carried out as described previously [6] . Briefly, the full-length GSKIP and GSKIP Drp1 690-736 fragments were purified and incubated with GSK3β (25 units 3000 Ci/mM). The assays were carried out for 15 min at 30°C. The reaction was stopped by adding 2 × sample buffer. Samples were denatured at 95°C for 5 min and separated by 8% SDS-PAGE. Signals were detected by autoradiography.
MTT assay
SH-SY5Y and HEK293 with GFP vector alone, GSKIP wt, and other mutant stable clones were seeded onto 96-well plates at 2 × 10 4 cells/ well in DMEM/F12 or DMEM medium and incubated for 24 h.
was added (final concentration, 0.5 mg/mL per well) and incubated for 2 h (37°C, 5% CO 2 ). The reaction was stopped by adding DMSO, and the formazan dye was solubilized. Optical densities were read at 595 nm using a microplate reader.
Statistical analysis
Data are presented as mean ± standard deviation. Statistical significance between the groups was examined using either Student's t-test or Wilcoxon's Rank-Sum test. p-Values less than 0.05 were considered statistically significant.
Results and discussion
PKA, GSKIP, GSK3β, and Drp1 may form a local working complex
We previously identified residue L130 of GSKIP as critical for binding to GSK3β; cells expressing the GSKIP-L130P mutant lose inhibition of SH-SY5Y neurite outgrowth [6, 8] . In this study, we further confirmed that GFP-tagged GSKIP but not the GFP-tagged GSKIP-L130P mutant is immunoprecipitated by anti-GSK3β antibody (Fig. 1A ). This data indicates that L130 is essential for GSK3β binding. Furthermore, our data showed that PKA RII (regulatory subunit type II) subunits are also immunoprecipitated by GFP-tagged GSKIP ( Fig. 1B and C) . However, the GFP-tagged GSKIP V41/L45P mutant failed to interact with PKA RII subunits (Fig. 1C) , which is consistent with earlier reports [7] . These data suggest that GSKIP may function as an AKAP to recruit the GSK3β and PKA RII subunits into close proximity. These findings also suggest that GSKIP forms a working complex with PKA RII, GSK3β, and Drp1.
Further, we examined whether GSKIP facilitates PKA-mediated phosphorylation of GSK3β S9. We detected a basal level of phosphorylated GSK3β S9 in all untreated cells. However, the level was higher in cells expressing GFP-GSKIP wt and the V41/L45P mutant than in those expressing the L130P mutant (Fig. 1D, left panel) . This observation indicates that the GSK3β binding domain of GSKIP effectively increases the phosphorylation of GSK3β S9. Forskolin is a direct activator of adenylyl cyclases and induces a rise in cAMP to activate PKA. When treated with forskolin, the phosphorylation level of GSK3β S9 was increased in all groups, but the original inter-group variations in GSK3β S9 phosphorylation were abolished (Fig. 1D, right panel) . Without forskolin induction, the phosphorylation level of the L130P mutant was relatively low compared to that of the other 3 groups, possibly because the L130P mutant is unable to bind GSK3β. We believe that the low phosphorylation level of GSK3β S9 in the GFP-alone group results from the inhibition of endogenous GSKIP upon GSK3β activation (Fig. 1D, left panel) . Together, these results suggest that GSKIP forms a local working complex with PKA RII, GSK3β, and Dp1 in the presence of forskolin (Fig. 1E) .
We postulate a hypothetical model in which GSKIP-induced inhibition of GSK3β-mediated Drp1 function takes place in 2 steps. First, GSKIP acts as a negative regulator of GSK3β through L130-mediated protein-protein interaction. Second, V41/L45 serves as a critical residue within the PKA binding domain of GSKIP. As a result, the binding of GSKIP to PKA may synergistically affect GSK3β activity via activation of GSK3β S9 phosphorylation. In contrast to our previous finding that GSKIP impairs GSK3β-mediated phosphorylation of Drp1 690-736 in a dose-dependent manner (Supplemental Fig. 1 ) [7] , the findings shown in Fig. 1 suggest that PKA signaling is essential for regulating Drp1 function locally. We thus speculate that GSK3β plays a multifaceted role in controlling Drp1 phosphorylation at multiple sites. In addition to phosphorylating Drp1 at S693 (pS693) through its kinase activity, GSK3β might anchor Drp1 (Fig. 1E) , thereby providing a substrate for PKA, which phosphorylates Drp1 at S637 (pS637) as well.
3.2. L130 but not V41/L45 is crucial for RA-induced neurite outgrowth, and both V41/L45 and L130 are associated with the protective action of GSKIP against H 2 O 2 -induced apoptosis
We previously demonstrated that overexpression of GSKIP but not the GSKIP L130P mutant prevents neurite outgrowth of SH-SY5Y when treated with RA [6] . Here, we further investigated whether V41/ L45, as a PKA binding site, plays a role similar to that of L130 in RAinduced neurite outgrowth. Our data robustly demonstrate that L130 is crucial for RA-induced neurite outgrowth, and the V41/L45 residues of GSKIP tethering it to PKA are not involved in preventing the neurite outgrowth (Fig. 2) . We further investigated stimuli that might alter GSKIP mRNA expression. A variety of stimuli, including Wnt signaling, glucose depletion, Aβ, H 2 O 2 , staurosporine (STS), forskolin, and insulin were implicated, but no treatment significantly induced GSKIP mRNA expression (Supplemental Figs. 2A & 2B) . We also investigated whether GSKIP plays a role in autophagy and found no significant difference in autophagy-related protein expression between the study groups (Supplemental Fig. 3) . Fig. 1 . GSKIP directly interacts with PKA and GSK3β as an AKAP. (A) GSKIP interacts with GSK3β via its C-terminal region. GFP-GSKIP wt or GFP-GSKIPL130P transfected cells were collected and total lysates were subjected to immunoprecipitation (IP) using anti-GSK3β antibody. The precipitates were then analyzed by immunoblotting with the anti-GFP antibody. (B) GSKIP interacts with the PKA RII region. GFP-GSKIP wt transfected cells were collected, and total lysates were subjected to IP using the anti-GFP antibody. The precipitates were then analyzed by immunoblotting with the anti-PKA RII antibody. (C) GFP-GSKIP wt, GFP-GSKIP L130P or GFP-GSKIP V41/L45P transfected cells were collected, and total lysates were subjected to IP using anti-GSK3β antibody. The resulting precipitates were then analyzed by immunoblotting with the anti-GFP, PKA RII, and Drp1 antibodies. (D) left panel: GFP or GFP-GSKIP wt and mutants were transiently expressed in SH-SY5Y cells. The cells were untreated (left) or incubated with 10 μM forskolin for 1 h (right). Cells were lysed, and the protein level analyzed with respect to GFP-GSKIP, phosphorylated (p-GSK3β), total GSK3β, and PKA substrate using specific antibodies. The dashed line indicates the region where separate blots were joined in this image. Because the L130P and V41/L45P mutants did not affect autophagy, we alternatively explored their role in apoptosis, since PKA-mediated phosphorylation of Drp1 at S637 confers resistance to H 2 O 2 -induced apoptosis [17] . A previous study suggests that S637 phosphorylation results in elongated mitochondrial morphology [12] . We used STS and H 2 O 2 to induce apoptosis and mitochondrial fragmentation, respectively. The basal levels of STS and H 2 O 2 cytotoxicity were determined, revealing that only H 2 O 2 had a minor influence on PKA signaling (data not shown). Cell proliferation assays using MTT showed that after treatment with either H 2 O 2 alone or H 2 O 2 plus forskolin, cells expressing GSKIP wt showed relatively minor decreases in proliferation compared to cells in other groups, indicating a possible protective effect of GSKIP wt against oxidative stress (Fig. 3A) . We determined the expression of cleaved PARP and caspase-3 as apoptotic markers in cells treated with H 2 O 2 (Fig. 3B ) or forskolin and H 2 O 2 (Fig. 3C) . Consistently, the expression of both cleaved PARP and caspase-3 was significantly higher in the V41/L45P-expressing cells than the GSKIP wt-expressing cells under 2 different conditions (H 2 O 2 alone and H 2 O 2 plus forskolin; Fig. 3B and C, respectively). Similarly, the activity of caspase 3 and 7 was significantly lower in GSKIP wt cells compared to those expressing either of the 2 mutants under both H 2 O 2 and H 2 O 2 plus forskolin treatment (Fig. 3D) . These results suggest that V41/L45 contributes to a protective effect against H 2 O 2 -induced apoptosis. Nevertheless, expression of cleaved caspase-3 was also higher in the L130P-expressing cells than GSKIP wt-expressing cells. Hence, L130 may also be involved in controlling apoptosis, even if its role is relatively minor compared to that of V41/L45.
3.3. V41/L45 and L130 affect Drp1-associated GSKIP protective action through a union of the two modes of GSKIP function involved in the cAMP/PKA/Drp1 axis As our results show, both V41/L45 and L130 may be involved in GSKIP's apoptosis-controlling role. However, the downstream effector of these 2 modes of GSKIP action remains unclear. Previously, we characterized L130 as critical for the interaction between GSKP and GSK3β. In addition, Drp1 phosphorylation by GSK3β (on S693) and PKA (on S637) both contribute to physiological neuroprotection against oxidative stress. Therefore, we tested whether Drp1 functions as a downstream effector, mediating the convergence of PKA and GSK3β signaling attributed to GSKIP and leading to a protective effect against H 2 O 2 -induced mitochondrial fragmentation. As shown in Fig. 4 , a basal level of pS637 Drp1 was detectable in all groups. However, the level was higher in cells expressing GFP-GSKIP wt than in other groups. Treatment with H 2 O 2 reduced the level of pS637 Drp1 and led to extreme mitochondrial fragmentation but increased the expression levels of GSK3β S9 and PKA substrates. Nonetheless, the level of pS637 Drp1 was increased by forskolin treatment, consistent with the results of a previous study [12] . These results indicate that PKA signaling was induced by forskolin, which has been presumed to affect the level of pS637 Drp1. However, our findings suggest two possible explanations for these results: 1) Another PKA-associated, GSKIP-involved signaling pathway may be involved; and 2) GSKIP is involved in regulating Drp1 S637 phosphorylation in this scenario through the cAMP/PKA/Drp1 signaling axis. Notably, PKA substrate signaling was enhanced by all treatments. Further, our data showed a significant difference in pS637 Drp1 between cells expressing GSKIP wt and those expressing the 2 mutant GSKIP variants under both conditions (forskolin alone and forskolin plus H 2 O 2 ). The level of pS637 Drp1 in cells expressing GSKIP wt was 7-8-fold higher than in mutant-expressing cells under both conditions (Fig. 4, lower panel) . In fact, without forskolin induction, GFP-GSKIP wt cells still showed relatively higher levels of pS637 Drp1. These observations suggest that V41/L45 and L130 are involved in the Drp1-associated GSKIP protective mechanism, which can be linked to cAMP/ PKA/Drp1 axis signaling.
Knockdown experiments reveal that GSKIP and GSK3β are involved in Camp/PKA/Drp1 axis signaling
To test whether GSKIP regulates the phosphorylation of Drp1 and/or GSK3β, we knocked down either GSKIP or GSK3 by siRNA while activating cAMP signaling. Additionally, we overexpressed wild-type GSKIP as a positive control for comparison with the 2 GSKIP mutants. As shown in Fig. 5A , our data confirmed the successfulness of GSKIP silencing at the mRNA level, causing a 51% reduction in GSKIP mRNA expression. Neurite outgrowth was unaffected by GSKIP knockdown (Fig. 5B) , which did not inhibit neurite outgrowth and was consistent with the result of cells expressing the L130P mutant compared to GSKIP wt and V41/L45P mutant (Fig. 2) . Moreover, in the presence of forskolin, the silencing of GSKIP expression led to a decrease in Drp1 S637, while GSKIP overexpression increased the levels of pS637 Drp1 and pS9 GSK3β (Fig. 5C ). These observations suggest that GSK3β acts as a scaffold protein that recruits Drp1 to PKA, which directly phosphorylates S637. The silencing of GSK3β but not GSK3α resulted in a dramatic decrease in pS637 Drp1 (Fig. 5D & E) . Further, overexpression of kinase-dead GSK3β K85R (which retains the capacity to bind GSKIP) but not K85M (which does not have the capacity to bind GSKIP) had no effect on pS637 Drp1 levels (Fig. 5F ). These data indicate that GSKIP and GSK3β coordinate to strengthen cAMP/PKA/Drp1 axis signaling. In addition, we observed that Drp1 phosphorylation at S637 is not mediated through GSK3β activity but through PKA signaling. Notably, in this case GSK3β appears to acts as an anchoring protein rather than as a kinase.
3.5. Overexpression of GSKIP Wt but not V41/L45P and L130P mutants decreased mitochondrial fragmentation and increased the number of mitochondria with elongated morphology under co-administration of H 2 O 2 and forskolin H 2 O 2 -induced apoptosis is usually accompanied by mitochondrial fragmentation during cell death. Previous reports suggest that overexpression of Drp1 S637D, a phosphomimetic mutant, leads to elongated mitochondrial morphology, which may be associated with acquired resistance to H 2 O 2 -induced apoptosis [7, 17] . We therefore examined the mitochondrial morphology consequent to Drp1 S637 phosphorylation in cells overexpressing each GSKIP variant under different conditions. As shown in Fig. 6A-D , the mitochondrial morphology of the control group was intermediate (~65%), with a small fraction of fragmented (~20%) or elongated (~15%) mitochondria. With H 2 O 2 treatment, the number of fragmented mitochondria was greater in cells expressing the GSKIP mutants (~57%) than in those expressing GSKIP wt (~42%) (Fig. 6B and D) . The number of intermediate mitochondria was slightly higher in the GSKIP wt cells (~50%) than in the other cells (~41%). In contrast, when cells were co-treated with forskolin and H 2 O 2 , those expressing GSKIP wt showed a significantly lower number of fragmented mitochondria (~35% vs. 44%-45%) and a slightly increased number of intermediate (~42% vs. 35%-38%) and elongated (~28% vs. 18%-20%) mitochondria compared to cells expressing the GSKIP mutants ( Fig. 6C and D) . However, it is noteworthy that when treated with forskolin alone, all cells showed a majority of elongated mitochondria regardless of H 2 O 2 insult or GSKIP variant expressed (Supplemental Fig. 4 ). This phenomenon is most likely the result of unopposed mitochondrial fusion due to PKA-mediated phosphorylation of Drp1 S637 [17] . These results suggest that the mitochondrial dynamics were regulated more dominantly by PKA signaling; however, this process is also modulated, at least in part, by GSKIP through its interaction with PKA RII and GSK3β.
To validate and confirm whether Drp1 was a downstream effector of GSKIP's protective action against H 2 O 2 -induced apoptosis, we ectopically expressed two Drp1 S637 mutants, S637A and S637D, in HeLa cells. As shown in Fig. 7 , overexpression of S637D, but not S637A, restored the elongated mitochondrial morphology in cells expressing each of the two GSKIP mutants. Together with the aforementioned findings, our results reveal that phosphorylation of Drp1 S637 is indeed regulated by GSKIP via coordination of its PKA and GSK3β binding domains. It should be noted that both GSKIP and GSK3 function as scaffolding proteins in our hypothetical complex ( Fig. 8 and Supplemental Fig. 5 ). Specifically, within this complex, GSK3 activity appears to be doubly inhibited by PKA-mediated phosphorylation at S9 of GSK3 and by direct protein-protein interaction with GSKIP.
In this study, we provide the first evidence to show that PKA/GSKIP/ GSK3β/Drp1 may form a complex in vitro (Fig. 1) . We further investigated the possible role of GSKIP V41/L45. Unlike L130, this site is unlikely to be involved in neurite outgrowth (Fig. 2) . V41/L45 was identified as responsible for GSKIP/PKA RII binding, as shown by immunoprecipitation, where V41/L45 mutations disrupted binding to PKA (Fig. 1C) . Although V41/L45 is not involved in neurite outgrowth, it participates in PKAmediated Drp1 phosphorylation. We propose that L130 has a function similar to that of V41/L45, but through a distinct mechanism (L130 function, GSK3β anchoring; V41/45 function, PKA RII binding) that participates in the control of apoptosis (Fig. 3) . Further, both V41/L45 and L130 are important for the Drp1-associated protective function of GSKIP. We clearly demonstrated that overexpression of GSKIP wt caused a 7-8 fold increase in pS637 Drp1 over that of the two GSKIP mutants (Fig. 4, right panel) . Conversely, knockdown of GSKIP and GSK3β revealed that they are required for cAMP/PKA/Drp1 axis signaling under oxidative stress (Fig. 5) .
The possible biological roles of GSKIP are summarized in Table 1 . Notably, GSKIP exerts protective control on mitochondrial morphology by coordinating the activation of PKA-mediated Drp1 phosphorylation at S637 and the GSK3β-mediated Drp1 recruitment. This recruitment is achieved by anchoring rather than the kinase activity of GSK3, even though the GSK3β activity is supposed to be downregulated by GSKIP-GSK3β binding. We therefore concluded that GSKIP and GSK3β participate in the cAMP/PKA/Drp1 axis by forming a working complex as PKA/GSKIP/GSK3β/Drp1 to modulate mitochondrial morphology, which sustains cell survival and controls neurite outgrowth. The roles of GSKIP are further discussed below in Section 3.7. 
The molecular switch of Drp1 phosphorylation is regulated by multifaceted signaling
Mitochondrial dynamics is tightly regulated by two major subclasses of proteins, fission and fusion proteins. Drp1 phosphorylation has been linked to elongated mitochondrial morphology and resistance to H 2 O 2 -induced cell death. We had expected that all cell types tested in this study (Fig. 6B) would show a phenotype of mitochondrial fragmentation, with GSK3β activity affected by H 2 O 2 (Fig. 3, panel H 2 O 2 ) . To the contrary, when treated with forskolin all cells showed a pattern of elongated mitochondrial morphology (Supplemental Fig. 4) . While the effect of the two GSKIP mutants (V41/L45P and L130P) on apoptosis was not clear, the co-administration of forskolin and H 2 O 2 resulted in elongated mitochondria only in cells expressing GSKIP wt (Fig. 6C) . The question of why only GSKIP wt caused the elongated mitochondrial morphology in the presence of forskolin and H 2 O 2 warranted further investigation.
Given the opposing effects of forskolin and H 2 O 2 on mitochondrial morphology, we further scrutinized the underlying molecular mechanism by which cAMP disrupts the H 2 O 2 insult. We concluded that the effect may be due to Drp1 phosphorylation, suggesting that Drp1 Ser637 confers mitochondrial elongation. Several of our findings support this postulation: 1) The GSKIP V41/L45P mutant is designated to prevent GSKIP binding to PKA RIIBD; in cells expressing this mutant, Drp1 S637 was not phosphorylated. 2) The GSKIP L130P mutant is unable to bind GSK3β, which serves as an anchor protein to recruit Drp1 for phosphorylation by PKA; cells expressing the L130P mutant failed to modulate Drp1 S637 phosphorylation. 3) Under H 2 O 2 treatment, decreased GSK3β but not PKA activity accounted for the low level of pS637 Drp1 (Fig. 4, panel H 2 O 2 ). 4) RNAi-based knockdown of GSKIP expression resulted in a dramatic decrease in Drp1 S637 phosphorylation (Fig. 5C ). 5) Silencing of GSK3β but not GSK3α resulted in decreased phosphorylation of Drp1 S637 (Fig. 5D & E) , indicating that only GSK3β is involved in cAMP/PKA/Drp1 axis signaling. Of note, this phenomenon is similar to the functional consequences of the previously reported GSK3β-K85M mutant, but not the GSK3β-K85R mutant (Fig. 5F) [25] . Together, the data shown in Figs. 4, 5, and 6 (confocal imaging) illustrate that PKA-mediated Drp1 phosphorylation at S637 and GSK3β-mediated Drp1 recruitment occur by anchoring, rather than kinase activity, to modulate mitochondrial morphology.
A model of GSKIP, GSK3β, PKA RII, and Drp1 interaction
Currently, two interaction patterns are reported for AKAP interaction with GSK3β, involving MAP2D, AKAP220, GSKIP, PS1 and Cos2. First, AKAPs facilitate inhibition of GSK3β, including MAP2D, AKAP220, and GSKIP. Second, the priming of the GSK3β substrate is mediated by PKA, including PS1 and Cos2 [26, 27] . Our convergent results, however, suggest a third model of AKAP tethering of GSK3β, in which GSK3β acts as an anchoring protein rather than a kinase. Unlike the interplay between GSK3β and GSKIP depicted in the first model of interaction, GSKIP tethers GSK3β to anchor Drp1, a mitochondrial fission protein, to regulate PKA-mediated phosphorylation of Drp1 at S637. This AKAP-like action is similar to the reported model of mAKAP/PDE4D3/E-pac1, in which PDE4D3 functions as an adaptor protein that recruits Epac1 [27] . In light of our findings, we hypothesize a model for the possible roles of GSKIP ( Fig. 8; Supplemental Fig. 5 ). Three mechanistic states are proposed in the model as follows. State 1: while activating cAMP signaling in the presence of GSKIP, GSKIP wt confers neuroprotection under H 2 O 2 -induced apoptosis. This process includes 3 major events: A) PKA binds GSKIP wt and facilitates GSK3β S9 phosphorylation. B) GSKIP negatively regulates GSK3β activity (by protein-protein interaction). The events in a and b represent a double inhibition of GSK3β activity that leads to Drp1 phosphorylation at S637 rather than S693. C) GSKIP mediates Drp1 phosphorylation at S637 by PKA (a novel pathway via GSK3β anchoring that was identified in this study; Table 1 ). State 2: In contrast to state 1, in the absence of GSKIP expression to negatively regulate GSK3β activity, GSK3β may act as a kinase to phosphorylate Knockdown of GSK3α expression (E) or kinase-inactive GSK3β K85R (F) had no effect on Drp1 Ser637 phosphorylation. Drp1 at S693 and regulate mitochondrial dynamics (Table 1) [7] . State 3: Alternatively, GSKIP, as an inhibitor of GSK3β through L130, mediates β-catenin ubiquitination during differentiation [6] .
Regardless of which prospective regulatory event predominates, our identification of GSKIP as a modulator of mitochondrial biology and the discovery of an anchored PKA/GSKIP/GSK3/Drp1 axis provide an 8 . Schematic of GSKIP, GSK3β, PKA RII, and Drp1 complex regulating mitochondrial functional. While activating cAMP signaling, GSKIP wt contributes neuroprotection from hydrogen peroxide-induced apoptosis via three modes: a. PKA binds GSKIP wt and facilitates GSK3β Ser9 phosphorylation. b. GSKIP negatively regulates GSK3β activity (previously characterized in Refs. [23] and [24] ); ⁎⁎ inhibition of GSK3β activity. c. GSKIP mediates Drp1 phosphorylation at Ser637 by PKA. Basically, GSKIP anchors Drp1 through L130 by tethering GSK3β for PKAmediated phosphorylation of Ser637. This event is thought to exert neuroprotective action through mitochondrial elongation: *neuroprotection (see also Supplemental Fig. 5 ). R: regulatory subunit of PKA. C: catalytic subunit of PKA.
important new mechanistic perspective on the essential role of GSKIP in regulating Drp1 phosphorylation during the dynamic mitochondrial response to H 2 O 2 -induced apoptosis [7, 26] . It is worth noting that recent studies have shown that the PKA/AKAP1/Drp1 complex also plays a role in mitochondrial function [17, 28] . Further studies should be conducted to determine whether these two AKAPs, GSKIP and AKAP1, have competitive, cooperative or distinctive functions and to determine their corresponding locations in Drp1-dependent mitochondrial fission.
Animal models of the PKA/GSKIP/GSK3/Drp1 signaling axis
Previous studies reported that Drp1 mutant or knockout (KO) led to early embryonic death and defective neurodevelopment [29] [30] [31] [32] [33] . In addition, GSK3β KO brought about developmental defects [34] due to hepatic apoptosis or cardiac patterning [35] . Studies also showed that PKA KO caused embryonic lethal and spinal neural tube defects [36] . These data collectively led us to believe that GSKIP may have a role in neurodevelopment. Our new model ( Fig. 8; Supplemental Fig. 5 ) clearly demonstrates that GSKIP is one of the major regulators of Drp1 S637 phosphorylation. It should be noted that some discrepancy may exist between results observed in cultured cells and in embryonic development, since we were unable to observe the functional consequences of neurite outgrowth after knockdown of GSKIP (Fig. 5B) . The fact that homologous GSKIP KO mice exhibited developmental lethality (data not shown) suggests that GSKIP is also important during development. The discrepancies between GSKIP knockdown in cultured cells and GSKIP KO mice could indicate that a partial deficiency in GSKIP expression may not have an evident phenotypic effect in neuronal development, or that other GSK3 signaling downstream events might counteract the action of GSKIP. To substantiate our proposed model, we plan to breed mice with tissue-specific GSKIP KO in the central nervous system to elucidate the role of GSKIP in neurodevelopment. A better understanding at the molecular level of the PKA/GSKIP/GSK3/Drp1 axis and the PKA signaling pathways involved in the pathogenesis of neurodegenerative diseases would help advance drug development for neuron-related disorders such as Alzheimer's disease [18] .
Conclusions
In this study, we provided evidence that GSKIP and GSK3β play central roles in the cAMP/PKA/GSKIP/GSK/Drp1 axis signaling that causes mitochondrial elongation under oxidative stress. Notably, GSKIP helps drive PKA-mediated Drp1 phosphorylation at Ser637 rather than Ser693 by tethering GSK3β. The GSKIP anchoring function of GSK3β is reported in this study for the first time. Particularly, we found that GSK3β participates in this axis as an anchoring protein, not a kinase. Our major findings may provide new insights into the multifaceted roles of GSK3β in cellular signaling and indicate the possible pharmaceutical use of GSKIP.
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